THIOGUANINE Drug Patent Profile
✉ Email this page to a colleague
When do Thioguanine patents expire, and what generic alternatives are available?
Thioguanine is a drug marketed by Waylis Therap and is included in one NDA.
The generic ingredient in THIOGUANINE is thioguanine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the thioguanine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Thioguanine
A generic version of THIOGUANINE was approved as thioguanine by WAYLIS THERAP on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for THIOGUANINE?
- What are the global sales for THIOGUANINE?
- What is Average Wholesale Price for THIOGUANINE?
Summary for THIOGUANINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 126 |
| Clinical Trials: | 101 |
| Patent Applications: | 7,480 |
| DailyMed Link: | THIOGUANINE at DailyMed |
Recent Clinical Trials for THIOGUANINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Children's Oncology Group | PHASE2 |
| Pfizer | PHASE2 |
| Amgen | PHASE2 |
Pharmacology for THIOGUANINE
| Drug Class | Antimetabolite |
Medical Subject Heading (MeSH) Categories for THIOGUANINE
US Patents and Regulatory Information for THIOGUANINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Waylis Therap | THIOGUANINE | thioguanine | TABLET;ORAL | 012429-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
